Paul Bisaro Net Worth & Insider Trades

Paul Bisaro - Director, Therapeuticsmd, Inc

As of August 22, 2022

What is Paul Bisaro's Net Worth?

The current estimated net worth of Therapeuticsmd, Inc's Director, Paul Bisaro, is estimated to be about $63.24M . Paul Bisaro owns about 196,864 units of Therapeuticsmd, Inc common stock. In the last 2 years at Therapeuticsmd, Inc, Paul Bisaro has sold an estimated value of $0 worth.

What is Paul Bisaro's Past Insider Trading?

Paul Bisaro's largest purchase order was 50,000 units , worth over $57K on June 8, 2020. In total, Paul Bisaro has made about 6 transactions over 2 years of their time at Therapeuticsmd, Inc. Paul Bisaro usually trades in August, with the busiest year in 2021. The most recent transaction was a purchase order of 50,000 units , worth over $39.5K on August 18, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Therapeuticsmd, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert G. Finizio 2020 $600,000 $1,524,751 - $600,000 $21,785 $2,746,536
Robert G. Finizio 2019 $600,000 - $2 $600,000 $22,218 $1,222,220
John C.K. Milligan, IV 2020 $450,000 $1,479,105 - $315,000 $31,285 $2,275,390
John C.K. Milligan, IV 2019 $450,000 - $645,956 $315,000 $29,683 $1,440,639
Edward Borkowski 2020 $430,000 - $3,599,967 $365,500 $81,687 $4,477,154
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm

What are Therapeuticsmd, Inc's Past Insider Trades?

Therapeuticsmd, Inc's most recent insider trade came on August 1, 2022 by Rubric Capital Management Lp and Efraim David Rosen who bought 580,000 units worth $15M . In the last 9 years, insiders at Therapeuticsmd, Inc have sold an estimated value of $50.32M and bought an estimated value of $20.27M worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are John C.K. Milligan IV, Secretary/CEO subsidiary,  Robert G Finizio, CEO,  and Tommy G Thompson, Director .

TherapeuticsMD, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1